| | NOVEMBER 20254Among the US President Donald Trump's tariff blackmails, the most consequential is a proposed 25 percent tariff hike on pharmaceutical imports. India and China remain pivotal players in the generic drug supply chain to the US Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance (IPA), recently emphasized that Indian pharmaceutical firms contribute nearly 47 percent of the generic medicines imported by the U.S., underscoring their role in delivering affordable, quality-assured treatments.However, the tariff decision introduces a new layer of complexity. President Trump has indicated that companies may seek exemptions by establishing manufacturing facilities within the US, potentially incentivizing Indian firms to localize operations. This development arrives at a time when India is gaining momentum on the global pharmaceutical stage, with innovation and expansion driving its strategic outlook.A timely reflection of this progress is the upcoming 74th Indian Pharmaceutical Congress (IPC), set to take place in Bengaluru in December 2025. As India's most prominent annual pharma event, IPC will convene stakeholders from industry, academia, and reg-ulatory bodies to spotlight advancements in drug development, manufacturing, and healthcare delivery. The conference is ex-pected to host a diverse mix of professionals and students, foster-ing dialogue on how Indian pharma can navigate emerging global challenges and opportunities.As this special issue highlights some of India's most reputed pharmaceutical and life sciences leaders who are piloting this transformation. We welcome your thoughts on how Indian pharmaceutical companies can adapt and thrive in this shifting global environment. Sujith VasudevanManaging Editoreditor@ceoinsightsindia.comIndian Pharma is Progressing EditorialVol 09 · Issue 01- 11 ·NOVEMBER, 2025 Publisher Alok ChaturvediSenior Designer Girisha M Visualiser Madhusmita SahooNoidaRohan S Jaspreet K advertise@ceoinsightsindia.comEditorial queries editor@ceoinsightsindia.comAdvertising ManagerRahul Das PattanaikTo subscribeVisit https://www.ceoinsightsindia.com/subscribe/ or send emailto subscription@ceoinsightsindia.comMagazine Price is Rs. 150 per issuePublisher Alok ChaturvediPrinted and Published By Alok Chaturvedi on behalf of InfoConnect Web Technologies India Pvt. Ltd., and Printed at Executive Prints - 113/7, Ground floor, Old madras road, Halasuru, Bangalore - 560008 and Published At No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugeshpalya, Bangalore-560017.Copyright © 2025 Info Connect Web Technologies India Pvt. Ltd., All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher.GM - Sales & Marketing Amrit SinghCirculation Manager Magendran Perumal Editorial Team Lakshmi Prabha S Keerthana Kantharaj Roopalatha H Viswanathan A Meriya Sabu Managing Editor Sujith Vasudevan
< Page 3 | Page 5 >